{"id":"https://openalex.org/W7212947206","doi":"https://doi.org/10.1007/s10637-026-01636-w","title":"First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors","display_name":"First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors","publication_year":2026,"publication_date":"2026-09-14","ids":{"openalex":"https://openalex.org/W7212947206","doi":"https://doi.org/10.1007/s10637-026-01636-w","pmid":"https://pubmed.ncbi.nlm.nih.gov/42734705"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-026-01636-w","doi":"https://doi.org/10.1007/s10637-026-01636-w","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-026-01636-w","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076489661","display_name":"Rachel Galot","orcid":"https://orcid.org/0000-0002-0596-4752","observed_orcids":["https://orcid.org/0000-0002-0596-4752"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Rachel Galot","raw_affiliation_strings":["Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium","P\u00f4le Oncologie, Institut de Recherche Clinique et Exp\u00e9rimentale, Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue Hippocrate 10, 1200, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium","institution_ids":["https://openalex.org/I1315288073"]},{"raw_affiliation_string":"P\u00f4le Oncologie, Institut de Recherche Clinique et Exp\u00e9rimentale, Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue Hippocrate 10, 1200, Brussels, Belgium","institution_ids":["https://openalex.org/I95674353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091693841","display_name":"Zahra Castel Ajgal","orcid":"https://orcid.org/0000-0002-2322-9612","observed_orcids":["https://orcid.org/0000-0002-2322-9612"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Zahra Castel-Ajgal","raw_affiliation_strings":["Institut Curie, 26 Rue d'Ulm, 75248, Paris cedex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Curie, 26 Rue d'Ulm, 75248, Paris cedex 05, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030523847","display_name":"Nuria Kotecki","orcid":"https://orcid.org/0000-0002-7753-230X","observed_orcids":["https://orcid.org/0000-0002-7753-230X"]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Nuria Kotecki","raw_affiliation_strings":["Institut Jules Bordet, Rue Meylemeersch, 90, 1070, Anderlecht, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Jules Bordet, Rue Meylemeersch, 90, 1070, Anderlecht, Belgium","institution_ids":["https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089622240","display_name":"Christiane Jungels","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Christiane Jungels","raw_affiliation_strings":["Institut Jules Bordet, Rue Meylemeersch, 90, 1070, Anderlecht, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Jules Bordet, Rue Meylemeersch, 90, 1070, Anderlecht, Belgium","institution_ids":["https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028020706","display_name":"Jean\u2010Pierre Delord","orcid":"https://orcid.org/0000-0001-7305-5561","observed_orcids":["https://orcid.org/0000-0001-7305-5561"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Pierre Delord","raw_affiliation_strings":["University of Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740","https://openalex.org/I4405258862"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020724418","display_name":"Iphig\u00e9nie Korakis","orcid":"https://orcid.org/0000-0002-2112-5932","observed_orcids":["https://orcid.org/0000-0002-2112-5932"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Iphigenie Korakis","raw_affiliation_strings":["University of Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Toulouse, Oncopole Claudius Regaud, IUCT-Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740","https://openalex.org/I4405258862"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040134869","display_name":"Samira El Farouk-Ameqrane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samira El-Farouk","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020194779","display_name":"Claire Jouffroy-Zeller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claire Jouffroy-Zeller","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109057985","display_name":"Anne Lise Quesnel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Quesnel","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108459770","display_name":"Carolina D. Duarte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carolina Duarte","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065821962","display_name":"Abdelkrim Taamma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdelkrim Taamma","raw_affiliation_strings":["AKT Clinical Development Consulting, 16 All\u00e9e du Bois de la Guiche, 91830, Le Coudray-Montceaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AKT Clinical Development Consulting, 16 All\u00e9e du Bois de la Guiche, 91830, Le Coudray-Montceaux, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5140153749","display_name":"Thomas Maurin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Maurin","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008115682","display_name":"Lola Lecru","orcid":"https://orcid.org/0000-0002-2780-408X","observed_orcids":["https://orcid.org/0000-0002-2780-408X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lola Lecru","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091538379","display_name":"Antoine Mousson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antoine Mousson","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059212188","display_name":"Orph\u00e9e Blanchard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Orph\u00e9e Blanchard","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109168099","display_name":"Anne\u2010Laure Blayo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne-Laure Blayo","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041101215","display_name":"Nathalie Lenne","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathalie Lenne","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051852907","display_name":"St\u00e9phan Schann","orcid":"https://orcid.org/0000-0001-7471-491X","observed_orcids":["https://orcid.org/0000-0001-7471-491X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephan Schann","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5151613270","display_name":"Xavier Leroy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xavier Leroy","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069419339","display_name":"Jean-Marie Cuillerot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Marie Cuillerot","raw_affiliation_strings":["Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kainova Therapeutics, 220 Boulevard Gonthier d'Andernach, 67400, Illkirch, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063649167","display_name":"Christophe Le Tourneau","orcid":"https://orcid.org/0000-0001-9772-4686","observed_orcids":["https://orcid.org/0000-0001-9772-4686"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christophe Le Tourneau","raw_affiliation_strings":["Institut Curie, 26 Rue d'Ulm, 75248, Paris cedex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Curie, 26 Rue d'Ulm, 75248, Paris cedex 05, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066800365","display_name":"Jean\u2010Pascal Machiels","orcid":"https://orcid.org/0000-0001-6369-9742","observed_orcids":["https://orcid.org/0000-0001-6369-9742"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Jean-Pascal Machiels","raw_affiliation_strings":["Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium. jean-pascal.machiels@saintluc.uclouvain.be","P\u00f4le Oncologie, Institut de Recherche Clinique et Exp\u00e9rimentale, Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue Hippocrate 10, 1200, Brussels, Belgium. jean-pascal.machiels@saintluc.uclouvain.be"],"raw_orcid":"https://orcid.org/0000-0001-6369-9742","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Institut Roi Albert II, Cliniques Universitaires Saint-Luc, Brussels, Belgium. jean-pascal.machiels@saintluc.uclouvain.be","institution_ids":["https://openalex.org/I1315288073","https://openalex.org/I95674353"]},{"raw_affiliation_string":"P\u00f4le Oncologie, Institut de Recherche Clinique et Exp\u00e9rimentale, Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue Hippocrate 10, 1200, Brussels, Belgium. jean-pascal.machiels@saintluc.uclouvain.be","institution_ids":["https://openalex.org/I95674353"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5066800365"],"corresponding_institution_ids":["https://openalex.org/I1315288073","https://openalex.org/I95674353"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"44","issue":"6","first_page":"457","last_page":"466"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ep4-receptor-antagonist","display_name":"EP4 receptor antagonist","score":0.9869999885559082},{"id":"https://openalex.org/keywords/prostaglandin-e2-receptor","display_name":"prostaglandin E2 receptor","score":0.9279999732971191},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.8700000047683716},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8790000081062317},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.949999988079071},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.972000002861023},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9890000224113464},{"id":"https://openalex.org/keywords/tnf-alpha-production","display_name":"TNF-alpha production","score":0.7910000085830688},{"id":"https://openalex.org/keywords/target-engagement","display_name":"target engagement","score":0.6610000133514404},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.3370000123977661},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.574999988079071},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8179000020027161},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.7728999853134155},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7526999711990356},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7340999841690063},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7114999890327454},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.6753000020980835},{"id":"https://openalex.org/C2779802037","wikidata":"https://www.wikidata.org/wiki/Q40878","display_name":"Diarrhea","level":2,"score":0.5965999960899353},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5794000029563904},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5715000033378601},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5353999733924866},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.427700012922287},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3982999920845032},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3700000047683716},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3422999978065491},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3409999907016754},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.3012000024318695},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.27379998564720154},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.2720000147819519},{"id":"https://openalex.org/C79410662","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Dose\u2013response relationship","level":2,"score":0.2662999927997589},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2565999925136566},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.25369998812675476}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058309","descriptor_name":"Receptors, Prostaglandin E, EP4 Subtype","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10637-026-01636-w","doi":"https://doi.org/10.1007/s10637-026-01636-w","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-026-01636-w","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmid:42734705","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42734705","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1892430921","https://openalex.org/W2010436550","https://openalex.org/W2019607817","https://openalex.org/W2031756196","https://openalex.org/W2113204284","https://openalex.org/W2155808278","https://openalex.org/W2173069051","https://openalex.org/W2173448806","https://openalex.org/W2727513755","https://openalex.org/W2752752185","https://openalex.org/W2886708232","https://openalex.org/W3036762572","https://openalex.org/W3105880108","https://openalex.org/W3137014047","https://openalex.org/W3203575974","https://openalex.org/W4224221646","https://openalex.org/W4295066745","https://openalex.org/W4311140977","https://openalex.org/W4364361272","https://openalex.org/W4379283160","https://openalex.org/W4384130505","https://openalex.org/W4391091171","https://openalex.org/W4404920980","https://openalex.org/W4412061896","https://openalex.org/W7163023854","https://openalex.org/W7211938674"],"related_works":["https://openalex.org/W4409688876","https://openalex.org/W4308384995","https://openalex.org/W4308384120","https://openalex.org/W3036762572","https://openalex.org/W4308382006","https://openalex.org/W7162496321","https://openalex.org/W3100570711","https://openalex.org/W3081187248","https://openalex.org/W4295066745","https://openalex.org/W4399326254"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-09-15T00:00:00"}